Search Results 361-370 of 16521 for Proliferation

  1. Mayo Researchers Extend Lifespan in Mice by as Much as 35 Percent

    “If translatable, because senescent cells do not proliferate rapidly, a drug could efficiently and quickly eliminate enough of them to have profound impacts on ...

  2. Lung cancer - Diagnosis and treatment - Mayo Clinic

    B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nature Medicine. 1999;5:1365. Aberle DR, et al ...

  3. Execute _Preview Minutes_ on HM00000252

    As a reminder to the lab, eye protection must be worn whenever there is the possibility of a spill or splash. All samples considered biosafety level 2/2+ ...

  4. Study to Determine the Safety and Effectiveness of Treating Macular Tetangiectasia Type 2 Patients with Renexus - Mayo Clinic

    ... proliferative diabetic retinopathy, uveitis); Participant has a chronic requirement (eg, ≥ 4 weeks at a time) for ocular medications and/or has a diagnosed ...

  5. Publications - Matthew T. Heller, M.D. - Mayo Clinic

    Neoplastic and proliferative disorders of the perinephric space. Clin Radiol. 2012 Nov; 67 (11):e31-41 Epub 2012 May 22. View PubMed; Heller MT, Hattoum A ...

  6. Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) - Mayo Clinic

    Severe diabetic retinopathy such as severe non-proliferative retinopathy and proliferative retinopathy. Major trauma including major surgery (such as ...

  7. A Study to Evaluate the Safety and Effectiveness of CAEL-101 and Plasma Cell Dyscrasia Treatment vs. Placebo and Plasma Cell Dyscrasia Tretment to Treat Patients with Mayo Stage IIIb AL Amyloidosis

    Evidence of end organ damage that can be attributed to the underlying plasma cell proliferative disorder (e.g., multiple myeloma and POEMS syndrome), ...

  8. Cardiovascular Medicine - Clinical trials

    The objective of this proposal is to assess blood-plasma volume (TBV-PV) status quantitatively in patients with DHF admitted to hospital for volume ...

  9. Publications - Gary L. Keeney, M.D. - Mayo Clinic

    Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers. Oncotarget. 2015 Nov 3; 6 (34): ...

  10. Inherited cancers clinic seeks to advance understanding, diagnosis and management of hereditary colorectal cancers - Mayo Clinic

    Histologically, JPS polyps show evidence of inflammation of lamina propria, thick mucin-filled cystic glands, with minimal smooth muscle proliferation. JPS ...